Sitagliptin

Sitagliptin is a DPP‑4 inhibitor with modest HbA1c reduction and cardiovascular neutrality; it has no demonstrated heart failure outcome benefit. DPP-4 inhibitors may in fact exacerbate heart failure symptoms through oedema worsening. This is not the best drug for Mr. Green.

Please go back and re-consider. 

  • Sitagliptin [undo]
  • DNA Ligase [undo]
  • Dapagliflozin [undo]
  • Joins an online support group. She does not want to see a therapist. [undo]
  • 37 °C, niveles atmosféricos de O₂, niveles atmosféricos de CO₂ [undo]
  • Exenatide [undo]
  • Use alcohol to soothe her pain [undo]
  • Pentru a ne proteja de orice scurgeri. Albul este o culoare în care cele mai multe scurgeri sunt vizibile, în funcție de culoarea soluției [undo]
  • Serum sodium [undo]
  • Adverse effect due to heparin [undo]
  • Ανάλυση λίθων και πλήρης μεταβολικός έλεγχος [undo]
  • Ask the patient to walk or change position (risk of falling). [undo]
  • LB [undo]
  • Temporarily stop taking metformin [undo]
  • Descrierea 3 [undo]
  • Οφθαλμολογική Εξέταση [undo]
  • MSA [undo]
  • Chlorpropamide [undo]
  • Isosorbide mononitrate (organic nitrate) [undo]
  • Sitagliptin [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21101
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway